Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/01/2009US20090247732 Synthesis of glycopeptides with superior pharmacokinetic properties
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247610 Integrase cofactor
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247605 Treating diseases mediated by metalloprotease-shed proteins
10/01/2009US20090247558 Use of the crh (corticotropin releasing hormone) - ucn (urocortin) system in the treatment of inflammatory diseases
10/01/2009US20090247482 50 Human Secreted Proteins
10/01/2009US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
10/01/2009US20090247473 Acythiols and component thiol compositions as anti-hiv and anti-retroviral agents
10/01/2009US20090247472 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
10/01/2009US20090247471 Inhibitors of cruzipain and other cysteine proteases
10/01/2009US20090247470 Phenylalanine dipeptide derivatives, compositions and use thereof
10/01/2009US20090247468 Spray drying a drug such as telaprevir; VX 770 is excluded; including a non-volatile or high boiling solvent during spray drying of a drug can improve the properties of resulting product
10/01/2009US20090247467 Peptide epitopes of vegfr-2/kdr that inhibit angiogenesis
10/01/2009US20090247466 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
10/01/2009US20090247465 Novel Use of Bivalirudin in the Treatment of Acute Coronary Syndrome
10/01/2009US20090247464 Compositions and Methods for Topical Application and Transdermal Delivery of an Oligopeptide
10/01/2009US20090247463 Polymer-based sustained release device
10/01/2009US20090247462 Fgf variants and methods for use thereof
10/01/2009US20090247461 Methods for therapeutic treatment of pain
10/01/2009US20090247460 Inhibitor of vascular endothelial cell growth factor
10/01/2009US20090247459 Modified recombinant factor viii and von willebrand factor and methods of use
10/01/2009US20090247458 Compositions and methods for treating cystic fibrosis
10/01/2009US20090247457 Neurotrophic components of the adnf i complex
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247455 Isolation of Inhibitors of IRES-Mediated Translation
10/01/2009US20090247454 Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
10/01/2009US20090247453 Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof
10/01/2009US20090247452 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
10/01/2009US20090247451 Therapeutic Compositions for Age-Related Macular Degeneration
10/01/2009US20090247450 G-csf liquid formulation
10/01/2009US20090246867 Glial mitogenic factors, their preparation and use
10/01/2009US20090246827 Recombinant toxin fragments
10/01/2009US20090246821 Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof
10/01/2009US20090246303 Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides
10/01/2009US20090246292 Antimicrobial formulations comprising a quinone and a copper salt
10/01/2009US20090246283 Repeat Sequence Protein Polymer Nanoparticles Optionally Containing Active Agents and Their Preparation
10/01/2009US20090246261 Fibrin foam and process for making
10/01/2009US20090246260 Fibrin foam and process
10/01/2009US20090246251 Coating compositions having improved performance
10/01/2009US20090246250 Coating compositions having improved performance
10/01/2009US20090246248 Coating compositions having improved performance
10/01/2009US20090246244 Malleable multi-component implants and materials therefor
10/01/2009US20090246238 Reinforced absorbable multilayered hemostatic wound dressing
10/01/2009US20090246228 Moraxella catarrhalis Proteins
10/01/2009US20090246217 Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity
10/01/2009US20090246211 Molecular constructs suitable for targeted conjugates
10/01/2009US20090246209 Gnrh analogues for treatment of urinary incontinence
10/01/2009US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009US20090246201 Substances
10/01/2009US20090246199 Therapeutic methods for inhibiting tumor growth with dll4 antagonists
10/01/2009US20090246196 Combined targeted therapy for the treatment of proliferative disease
10/01/2009US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
10/01/2009US20090246188 Method for Production of a Bioengineered Form of Tissue Plasminogen Activator
10/01/2009US20090246187 Process for concentration of a polypeptide
10/01/2009US20090246183 eNOS mutations useful for gene therapy and therapeutic screening
10/01/2009US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009US20090246175 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases
10/01/2009US20090246174 Treatment for cutaneous t cell lymphoma
10/01/2009US20090246173 Treatment with anti-vegf antibodies
10/01/2009US20090246172 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
10/01/2009US20090246171 Automatic system for dose control in treating hepatitis c using infusion pumps
10/01/2009US20090246170 Therapeutic Agent For Alzheimer's Disease
10/01/2009US20090246169 Indolopyridines as eg5 kinesin modulators
10/01/2009US20090246168 Antitumoral treatments
10/01/2009US20090246167 Stimuli-responsive systems for controlled drug delivery
10/01/2009US20090246150 Antimicrobial composition
10/01/2009US20090246142 Triggered Self-Assembly of Nanoparticles In Vivo
10/01/2009US20090246139 Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior
10/01/2009US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction
10/01/2009US20090246129 Compositions and methods for the diagnosis and treatment of tumor
10/01/2009US20090246124 High affinity vegf-receptor antagonists
10/01/2009US20090241950 Method of treating diabetes mellitus in a patient
10/01/2009CA2722621A1 Thrombin derived peptides for smooth muscle relaxation
10/01/2009CA2722620A1 Method of treating peripheral arterial disease
10/01/2009CA2722618A1 Method of treating degenerative diseases
10/01/2009CA2719857A1 Leucine-rich peptide compositions and methods for isolation
10/01/2009CA2719803A1 Compositions and methods for the preparation of nanoemulsions
10/01/2009CA2719707A1 Therapy for vitiligo
10/01/2009CA2719582A1 Neurodegenerative disorders
10/01/2009CA2719272A1 Methods and compositions for oral administration of proteins
10/01/2009CA2719254A1 Collagen-binding synthetic peptidoglycans, preparation, and methods of use
10/01/2009CA2719061A1 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network
10/01/2009CA2719059A1 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
10/01/2009CA2718412A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
10/01/2009CA2718296A1 Agent for treating skin aging and scars
10/01/2009CA2718146A1 Novel n- and c-terminal substituted antagonistic analogs of gh-rh
10/01/2009CA2718093A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009CA2716189A1 Ophthalmic compositions comprising a dipeptide
10/01/2009CA2715816A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3
09/2009
09/30/2009EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009EP2105497A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
09/30/2009EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein
09/30/2009EP2105142A1 Means and methods for influencing electrical activity of cells
09/30/2009EP2105141A1 Short bioactive peptides and methods for their use
09/30/2009EP2105138A2 Regeneration and augmentation of bone using mesenchymal stem cells
09/30/2009EP2105137A1 A novel use of bivalirudin in the treatment of acute coronary syndrome
09/30/2009EP2104684A1 Peptides for use in the treatment of obesity
1 ... 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 ... 3163